Loading...

Rastogi Anjay

TitleDirector
InstitutionUniversity of California Los Angeles
DepartmentOutpatient Nephrology
Address10630 Santa Monica Blvd.
LOS ANGELES CA 90025
Phone(310) 206-6741
vCardDownload vCard
    Other Positions
    TitleDirector

    TitleDirector

    TitleClinical Director

    TitleMedical Director

    TitleAssociate Professor


    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Rastogi A, Chertow GM. Mandating Staffing Ratios in Hemodialysis Facilities: California SB 349 and Unintended Consequences. Clin J Am Soc Nephrol. 2018 Jun 06. PMID: 29875201.
      View in: PubMed
    2. Ketteler M, Sprague SM, Covic AC, Rastogi A, Spinowitz B, Rakov V, Walpen S, Floege J. Effects of sucroferric oxyhydroxide and sevelamer carbonate on chronic kidney disease-mineral bone disorder parameters in dialysis patients. Nephrol Dial Transplant. 2018 May 29. PMID: 29846719.
      View in: PubMed
    3. Beddhu S, Rocco MV, Toto R, Craven TE, Greene T, Bhatt U, Cheung AK, Cohen D, Freedman BI, Hawfield AT, Killeen AA, Kimmel PL, Lash J, Papademetriou V, Rahman M, Rastogi A, Servilla K, Townsend RR, Wall B, Whelton PK. Effects of Intensive Systolic Blood Pressure Control on Kidney and Cardiovascular Outcomes in Persons Without Kidney Disease: A Secondary Analysis of a Randomized Trial. Ann Intern Med. 2017 Sep 19; 167(6):375-383. PMID: 28869987.
      View in: PubMed
    4. Bress AP, King JB, Kreider KE, Beddhu S, Simmons DL, Cheung AK, Zhang Y, Doumas M, Nord J, Sweeney ME, Taylor AA, Herring C, Kostis WJ, Powell J, Rastogi A, Roumie CL, Wiggers A, Williams JS, Yunis R, Zias A, Evans GW, Greene T, Rocco MV, Cushman WC, Reboussin DM, Feinglos MN, Papademetriou V. Effect of Intensive Versus Standard Blood Pressure Treatment According to Baseline Prediabetes Status: A Post Hoc Analysis of a Randomized Trial. Diabetes Care. 2017 Aug 09. PMID: 28793997.
      View in: PubMed
    5. Covic AC, Floege J, Ketteler M, Sprague SM, Lisk L, Rakov V, Rastogi A. Iron-related parameters in dialysis patients treated with sucroferric oxyhydroxide. Nephrol Dial Transplant. 2017 Aug 01; 32(8):1330-1338. PMID: 27342579.
      View in: PubMed
    6. Arman F, Shakeri H, Nobakht N, Rastogi A, Kamgar M. A Case of Kidney Involvement in Primary Sjögren's Syndrome. Am J Case Rep. 2017 Jun 03; 18:622-626. PMID: 28577018.
      View in: PubMed
    7. Arman F, Shakeri H, Nobakht N, Rastogi A, Kamgar M. Erdheim-Chester Disease Presenting with Secondary Hypertension as a Result of Bilateral, Proximal Renal Artery Stenosis: A Case Report. Case Rep Nephrol Dial. 2017 May-Aug; 7(2):55-62. PMID: 28612007.
      View in: PubMed
    8. Upadhya B, Rocco M, Lewis CE, Oparil S, Lovato LC, Cushman WC, Bates JT, Bello NA, Aurigemma G, Fine LJ, Johnson KC, Rodriguez CJ, Raj DS, Rastogi A, Tamariz L, Wiggers A, Kitzman DW. Effect of Intensive Blood Pressure Treatment on Heart Failure Events in the Systolic Blood Pressure Reduction Intervention Trial. Circ Heart Fail. 2017 Apr; 10(4). PMID: 28364091.
      View in: PubMed
    9. Patel S, Nguyen DS, Rastogi A, Nguyen MK, Nguyen MK. Treatment of Cirrhosis-Associated Hyponatremia with Midodrine and Octreotide. Front Med (Lausanne). 2017; 4:17. PMID: 28352627.
      View in: PubMed
    10. Sprague SM, Covic AC, Floege J, Ketteler M, Botha J, Chong EM, Rastogi A. Pharmacodynamic Effects of Sucroferric Oxyhydroxide and Sevelamer Carbonate on Vitamin D Receptor Agonist Bioactivity in Dialysis Patients. Am J Nephrol. 2016; 44(2):104-12. PMID: 27434393.
      View in: PubMed
    11. Rastogi A, Arman F, Alipourfetrati S. New Agents in Treatment of Hyperkalemia: an Opportunity to Optimize Use of RAAS Inhibitors for Blood Pressure Control and Organ Protection in Patients with Chronic Kidney Disease. Curr Hypertens Rep. 2016 Jul; 18(7):55. PMID: 27230070.
      View in: PubMed
    12. Chang TI, Evans G, Cheung AK, Cushman WC, Diamond MJ, Dwyer JP, Huan Y, Kitzman D, Kostis JB, Oparil S, Rastogi A, Roumie CL, Sahay R, Stafford RS, Taylor AA, Wright JT, Chertow GM. Patterns and Correlates of Baseline Thiazide-Type Diuretic Prescription in the Systolic Blood Pressure Intervention Trial. Hypertension. 2016 Mar; 67(3):550-5. PMID: 26865200; PMCID: PMC4755350 [Available on 03/01/17].
    13. Holdstock L, Meadowcroft AM, Maier R, Johnson BM, Jones D, Rastogi A, Zeig S, Lepore JJ, Cobitz AR. Four-Week Studies of Oral Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor GSK1278863 for Treatment of Anemia. J Am Soc Nephrol. 2016 Apr; 27(4):1234-44. PMID: 26494831; PMCID: PMC4814173 [Available on 04/01/17].
    14. Floege J, Covic AC, Ketteler M, Mann JF, Rastogi A, Spinowitz B, Chong EM, Gaillard S, Lisk LJ, Sprague SM. Long-term effects of the iron-based phosphate binder, sucroferric oxyhydroxide, in dialysis patients. Nephrol Dial Transplant. 2015 Jun; 30(6):1037-46. PMID: 25691681; PMCID: PMC4438742.
    15. Bacchetta J, Chun RF, Gales B, Zaritsky JJ, Leroy S, Wesseling-Perry K, Boregaard N, Rastogi A, Salusky IB, Hewison M. Antibacterial responses by peritoneal macrophages are enhanced following vitamin D supplementation. PLoS One. 2014; 9(12):e116530. PMID: 25549329; PMCID: PMC4280222.
    16. Floege J, Covic AC, Ketteler M, Rastogi A, Chong EM, Gaillard S, Lisk LJ, Sprague SM. A phase III study of the efficacy and safety of a novel iron-based phosphate binder in dialysis patients. Kidney Int. 2014 Sep; 86(3):638-47. PMID: 24646861; PMCID: PMC4150998.
    17. Rastogi A. Sevelamer revisited: pleiotropic effects on endothelial and cardiovascular risk factors in chronic kidney disease and end-stage renal disease. Ther Adv Cardiovasc Dis. 2013 Dec; 7(6):322-42. PMID: 24327730; PMCID: PMC3917706.
    18. Raza A, Ravandi F, Rastogi A, Bubis J, Lim SH, Weitz I, Castro-Malaspina H, Galili N, Jawde RA, Illingworth A. A prospective multicenter study of paroxysmal nocturnal hemoglobinuria cells in patients with bone marrow failure. Cytometry B Clin Cytom. 2014 May; 86(3):175-82. PMID: 24227693.
      View in: PubMed
    19. Zaritsky J, Rastogi A, Fischmann G, Yan J, Kleinman K, Chow G, Gales B, Salusky IB, Wesseling-Perry K. Short daily hemodialysis is associated with lower plasma FGF23 levels when compared with conventional hemodialysis. Nephrol Dial Transplant. 2014 Feb; 29(2):437-41. PMID: 24009282; PMCID: PMC3910340.
    20. Covic A, Rastogi A. Hyperphosphatemia in patients with ESRD: assessing the current evidence linking outcomes with treatment adherence. BMC Nephrol. 2013 Jul 18; 14:153. PMID: 23865421; PMCID: PMC3728082.
    21. Ornt DB, Larive B, Rastogi A, Rashid M, Daugirdas JT, Hernandez A, Kurella Tamura M, Suri RS, Levin NW, Kliger AS. Impact of frequent hemodialysis on anemia management: results from the Frequent Hemodialysis Network (FHN) Trials. Nephrol Dial Transplant. 2013 Jul; 28(7):1888-98. PMID: 23358899; PMCID: PMC3707527.
    22. Moise PA, Amodio-Groton M, Rashid M, Lamp KC, Hoffman-Roberts HL, Sakoulas G, Yoon MJ, Schweitzer S, Rastogi A. Multicenter evaluation of the clinical outcomes of daptomycin with and without concomitant ß-lactams in patients with Staphylococcus aureus bacteremia and mild to moderate renal impairment. Antimicrob Agents Chemother. 2013 Mar; 57(3):1192-200. PMID: 23254428; PMCID: PMC3591880.
    23. Murali S, Arab L, Vargas R, Rastogi A, Ang A, Shetty N. Internet-based tools to assess diet and provide feedback in chronic kidney disease stage IV: a pilot study. J Ren Nutr. 2013 Mar; 23(2):e33-42. PMID: 22819321.
      View in: PubMed
    24. Hahn BH, McMahon MA, Wilkinson A, Wallace WD, Daikh DI, Fitzgerald JD, Karpouzas GA, Merrill JT, Wallace DJ, Yazdany J, Ramsey-Goldman R, Singh K, Khalighi M, Choi SI, Gogia M, Kafaja S, Kamgar M, Lau C, Martin WJ, Parikh S, Peng J, Rastogi A, Chen W, Grossman JM. American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis. Arthritis Care Res (Hoboken). 2012 Jun; 64(6):797-808. PMID: 22556106; PMCID: PMC3437757.
    25. Rastogi A, Rashid M, Wright RF. Reducing cardiorenal risk through combination therapy with a direct renin inhibitor. J Clin Hypertens (Greenwich). 2011 Nov; 13(11):848-55. PMID: 22051431.
      View in: PubMed
    26. Rosner MH, Rastogi A, Ronco C. The cardiorenal syndrome. Int J Nephrol. 2011; 2011:982092. PMID: 21761003; PMCID: PMC3133432.
    27. Nobakht N, Kamgar M, Rastogi A, Schrier RW. Limitations of angiotensin inhibition. Nat Rev Nephrol. 2011 06; 7(6):356-9. PMID: 21502972.
      View in: PubMed
    28. Unruh M, Kurella Tamura M, Larive B, Rastogi A, James S, Schiller B, Gassman J, Chan C, Lockridge R, Kliger A. Impact of sleep quality on cardiovascular outcomes in hemodialysis patients: results from the frequent hemodialysis network study. Am J Nephrol. 2011; 33(5):398-406. PMID: 21474924; PMCID: PMC3080580.
    29. In-center hemodialysis six times per week versus three times per week. N Engl J Med. 2010 Dec 09; 363(24):2287-300. PMID: 21091062; PMCID: PMC3042140.
    30. Zaritsky J, Young B, Gales B, Wang HJ, Rastogi A, Westerman M, Nemeth E, Ganz T, Salusky IB. Reduction of serum hepcidin by hemodialysis in pediatric and adult patients. Clin J Am Soc Nephrol. 2010 Jun; 5(6):1010-4. PMID: 20299375; PMCID: PMC2879302.
    31. Rastogi A, Nissenson AR. Technological advances in renal replacement therapy: five years and beyond. Clin J Am Soc Nephrol. 2009 Dec; 4 Suppl 1:S132-6. PMID: 19995997.
      View in: PubMed
    32. Ye X, Rastogi A, Nissenson AR. Renal replacement therapy in the elderly. Clin Geriatr Med. 2009 Aug; 25(3):529-42. PMID: 19765494.
      View in: PubMed
    33. Watson MJ, Venick RS, Kaldas F, Rastogi A, Gordon SA, Colangelo J, Esmailian Y, McDiarmid SV, Busuttil RW, Farmer DG. Renal function impacts outcomes after intestinal transplantation. Transplantation. 2008 Jul 15; 86(1):117-22. PMID: 18622288.
      View in: PubMed
    34. Rastogi A, Fonarow GC. The cardiorenal connection in heart failure. Curr Cardiol Rep. 2008 May; 10(3):190-7. PMID: 18489862.
      View in: PubMed
    35. Rastogi A, Itagaki B, Bajwa M, Kraut JA. Spurious elevation in serum creatinine caused by ingestion of nitromethane: implication for the diagnosis and treatment of methanol intoxication. Am J Kidney Dis. 2008 Jul; 52(1):181-7. PMID: 18589218.
      View in: PubMed
    36. Rastogi A, Linden A, Nissenson AR. Disease management in chronic kidney disease. Adv Chronic Kidney Dis. 2008 Jan; 15(1):19-28. PMID: 18155106.
      View in: PubMed
    37. Rastogi A, Nissenson AR. The future of renal replacement therapy. Adv Chronic Kidney Dis. 2007 Jul; 14(3):249-55. PMID: 17603978.
      View in: PubMed
    38. Nguyen MK, Rastogi A, Kurtz I. True hyponatremia secondary to intravenous immunoglobulin. Clin Exp Nephrol. 2006 Jun; 10(2):124-6. PMID: 16791398.
      View in: PubMed